Effects of oats on plasma cholesterol and lipoproteins in C57BL/6 mice are substrain specific

British Journal of Nutrition

Volumn 103, Issue 4, 2010, Pages 513-521

  Andersson, Kristina E ^a   Immerstrand, Tina ^b   Säwrd, Karl ^a   Bergenståhl, Böjrn ^b   Lindholm, Marie W ^b   Öste, Rickard ^b   Hellstrand, Per ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Glucans; Atherosclerosis; Cholesterol; Dietary Fibres; Lipoproteins

Indexed keywords

BETA GLUCAN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN; AUTACOID; CHOLESTEROL; CHOLIC ACID; HYPOCHOLESTEROLEMIC AGENT; LIPOPROTEIN; PLANT MEDICINAL PRODUCT;

ANIMAL EXPERIMENT; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; BODY WEIGHT; BRAN; C57BL 6 MOUSE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FECES ANALYSIS; FEMALE; GENETIC VARIABILITY; INFLAMMATION; LIPOPROTEIN BLOOD LEVEL; MOUSE; NONHUMAN; OAT; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; C57BL MOUSE; DISEASE MODEL; FAT INTAKE; FECES; GENETICS; HYPERCHOLESTEROLEMIA; METABOLISM; PLANT SEED; SPECIES DIFFERENCE;

ANIMALIA; AVENA; MUS;

ANIMALS; ANTICHOLESTEREMIC AGENTS; ATHEROSCLEROSIS; AVENA SATIVA; CHOLESTEROL; CHOLIC ACID; DIET, ATHEROGENIC; DIETARY FATS; DISEASE MODELS, ANIMAL; FECES; FEMALE; GENETIC VARIATION; HYPERCHOLESTEROLEMIA; INFLAMMATION MEDIATORS; LIPOPROTEINS; MICE; MICE, INBRED C57BL; PLANT PREPARATIONS; SEEDS; SPECIES SPECIFICITY;

EID: 77649198133     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711450999211X     Document Type: Article

References (53)

1. Biorklund M, van Rees A, Mensink RP, et al. (2005) Changes in serum lipids and postprandial glucose and insulin concentrations after consumption of beverages with beta-glucans from oats or barley: a randomised dose-controlled trial. Eur J Clin Nutr 59, 1272-1281.
2. Kerckhoffs DA, Brouns F, Hornstra G, et al. (2002) Effects on the human serum lipoprotein profile of beta-glucan, soy protein and isoflavones, plant sterols and stanols, garlic and tocotrie-nols. J Nutr 132, 2494-2505.
3. Lia A, Hallmans G, Sandberg AS, et al. (1995) Oat beta-glucan increases bile acid excretion and a fiber-rich barley fraction increases cholesterol excretion in ileostomy subjects. Am J Clin Nutr 62, 1245-1251.
4. Ripsin CM, Keenan JM, Jacobs DR, et al. (1992) Oat products and lipid lowering. A meta-analysis. JAMA 267, 3317-3325.
5. Saltzman E, Das SK, Lichtenstein AH, et al. (2001) An oat-containing hypocaloric diet reduces systolic blood pressure and improves lipid profile beyond effects of weight loss in men and women. J Nutr 131, 1465-1470.
6. Czerwinski J, Bartnikowska E, Leontowicz H, et al. (2004) Oat (Avena sativa L.) and amaranth (Amaranthus hypochondriacus) meals positively affect plasma lipid profile in rats fed cholesterol-containing diets. J Nutr Biochem 15, 622-629.
7. De Schrijver R, Fremaut D & Verheyen A (1992) Cholesterol-lowering effects and utilization of protein, lipid, fiber and energy in rats fed unprocessed and baked oat bran. J Nutr 122, 1318-1324.
8. Delaney B, Nicolosi RJ, Wilson TA, et al. (2003) Beta-glucan fractions from barley and oats are similarly antiatherogenic in hypercholesterolemic Syrian golden hamsters. J Nutr 133, 468-475.
9. Malkki Y, Torronen R, Pelkonen K, et al. (1993) Effects of oat-bran concentrate on rat serum lipids and liver fat infiltration. Br J Nutr 70, 767-776.
10. FDA allows whole oat foods to make health claim on reducing the risk of heart disease. In FDA Talk Paper T97-5, January 21, 1997.
11. Brown L, Rosner B, Willett WW, et al. (1999) Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 69, 30-42.
12. Kelly SA, Summerbell CD, Brynes A, et al. (2007) Wholegrain cereals for coronary heart disease. The Cochrane Database of Systematic Reviews CD005051.
13. Beer MU, Wood PJ, Weisz J, et al. (1997) Effect of Cooking and storage on the amount and molecular weight of (1 ! 3)(1 ! 4)b-D-glucan extracted from oat products by an in vitro digestion system. Cereal Chem 74, 705-709.
14. Andersson M, Ellegard L & Andersson H (2002) Oat bran stimulates bile acid synthesis within 8 h as measured by 7alpha-hydroxy-4-cholesten-3-one. Am J Clin Nutr 76, 1111-1116.
15. Blackburn NA, Redfern JS, Jarjis H, et al. (1984) The mechanism of action of guar gum in improving glucose tolerance in man. Clin Sci (Lond) 66, 329-336.
16. Drzikova B, Dongowski G & Gebhardt E (2005) Dietary fibre-rich oat-based products affect serum lipids, microbiota, formation of short-chain fatty acids and steroids in rats. Br J Nutr 94, 1012-1025.
17. Lund EK, Gee JM, Brown JC, et al. (1989) Effect of oat gum on the physical properties of the gastrointestinal contents and on the uptake of D-galactose and cholesterol by rat small intestine in vitro. Br J Nutr 62, 91-101.
18. Theuwissen E & Mensink RP (2008) Water-soluble dietary fibers and cardiovascular disease. Physiol Behav 94, 285-292.
19. Wood PJ, Braaten JT, Scott FW, et al. (1994) Effect of dose and modification of viscous properties of oat gum on plasma glucose and insulin following an oral glucose load. Br J Nutr 72, 731-743.
20. Yang JL, Kim YH, Lee HS, et al. (2003) Barley beta-glucan lowers serum cholesterol based on the up-regulation of cholesterol 7alpha-hydroxylase activity and mRNA abundance in cholesterol-fed rats. J Nutr Sci Vitaminol (Tokyo) 49, 381-387.
21. Peterson D (2001) Oat antioxidants. J Cereal Sci 33, 115-129.
22. Pettersson D & Aman P (1992) Production responses and serum lipid concentration of broiler chickens fed diets based on oat bran and extracted oat bran with and without enzyme supplementation. J Sci Food Agric 58, 569-576.
23. Paigen B, Mitchell D, Reue K, et al. (1987) Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Proc Natl Acad Sci USA 84, 3763-3767.
24. Kirk EA, Sutherland P & Wang SA (1998) Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. J Nutr 128, 954-959.
25. Chan MY & Heng CK (2008) Sequential effects of a high-fiber diet with psyllium husks on the expression levels of hepatic genes and plasma lipids. Nutrition 24, 57-66.
26. Matsumoto K, Watanabe Y, Ohya MA, et al. (2006) Young persimmon fruits prevent the rise in plasma lipids in a diet-induced murine obesity model. Biol Pharm Bull 29, 2532-2535.
27. Murakami S, Kondo-Ohta Y & Tomisawa K (1999) Improvement in cholesterol metabolism in mice given chronic treatment of taurine and fed a high-fat diet. Life Sci 64, 83-91.
28. Hundemer JK, Nabar SP, Shriver BJ, et al. (1991) Dietary fiber sources lower blood cholesterol in C57BL/6 mice. J Nutr 121, 1360-1365.
29. J Overton (editor) (1995) Nutrient requirement of the mouse. In Nutrient Requirements of Laboratory Animals, 4th ed., pp. 80-102. National Research Council. Washington: National Academy Press.
30. Fulcher R (1986) Morphological and chemical characterization of the oat kernel. In Oats: Chemistry and Technology, pp. 47-73 [F Webster, editor]. St Paul, MN: American Association of Cereal Chemists.
31. McCleary BV & Codd R (1991) Measurement of (1 ! 3), (1 ! 4)-beta-glucan in barley and oats: a streamlined enzymic procedure. J Sci Food Agric 55, 303-312.
32. Tosh SM, Brummer Y, Wolever TMS, et al. (2008) Glycemic response to oat bran muffins treated to vary molecular weight of b-glucan. Cereal Chem 85, 211-217.
33. Noble RP (1968) Electrophoretic separation of plasma lipopro-teins in agarose gel. J Lipid Res 9, 693-700.
34. Hara A & Radin NS (1978) Lipid extraction of tissues with a low-toxicity solvent. Anal Biochem 90, 420-426.
35. Lindegaard ML, Damm P, Mathiesen ER, et al. (2006) Placental triglyceride accumulation in maternal type 1 diabetes is associated with increased lipase gene expression. J Lipid Res 47, 2581-2588.
36. Schreyer SA, Wilson DL & LeBoeuf RC (1998) C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis. Atherosclerosis 136, 17-24.
37. Kasbo J, Tuchweber B, Perwaiz S, et al. (2003) Phosphatidyl-choline- enriched diet prevents gallstone formation in mice susceptible to cholelithiasis. J Lipid Res 44, 2297-2303.
38. Nishina PM, Verstuyft J & Paigen B (1990) Synthetic low and high fat diets for the study of atherosclerosis in the mouse. J Lipid Res 31, 859-869.
39. Tepperman J, Caldwell FT & Tepperman HM (1964) Induction of gallstones in mice by feeding a cholesterol-cholic acid containing diet. Am J Physiol 206, 628-634.
40. Khanuja B, Cheah YC, Hunt M, et al. (1995) Lith1, a major gene affecting cholesterol gallstone formation among inbred strains of mice. Proc Natl Acad Sci USA 92, 7729-7733.
41. Maurer KJ, Rogers AB,GeZ, etal. (2006) Helicobacter pylori and cholesterol gallstone formation in C57L/J mice: a prospective study. Am J Physiol Gastrointest Liver Physiol 290, G175-G182.
42. Ishida BY, Blanche PJ, Nichols AV, et al. (1991) Effects of atherogenic diet consumption on lipoproteins in mouse strains C57BL/6 and C3H. J Lipid Res 32, 559-568.
43. Volman JJ, Ramakers JD & Plat J (2008) Dietary modulation of immune function by beta-glucans. Physiol Behav 94, 276-284.
44. Queenan KM, Stewart ML, Smith KN, et al. (2007) Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr J 6, 6.
45. Theuwissen E, Plat J & Mensink RP (2009) Consumption of oat beta-glucan with or without plant stanols did not influence inflammatory markers in hypercholesterolemic subjects. Mol Nutr Food Res 53, 370-376.
46. Mulligan MK, Ponomarev I, Boehm SL, et al. (2008) Alcohol trait and transcriptional genomic analysis of C57BL/6 substrains. Genes Brain Behav 7, 677-689.
47. Roth DM, Swaney JS, Dalton ND, et al. (2002) Impact of anesthesia on cardiac function during echocardiography in mice. Am J Physiol Heart Circ Physiol 282, H2134-H2140.
48. Green ML, Singh AV, Zhang Y, et al. (2007) Reprogramming of genetic networks during initiation of the fetal alcohol syndrome. Dev Dyn 236, 613-631.
49. Toye AA, Lippiat JD, Proks P, et al. (2005) A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice. Diabetologia 48, 675-686.
50. Freeman HC, Hugill A, Dear NT, et al. (2006) Deletion of nicotinamide nucleotide transhydrogenase: a new quantitive trait locus accounting for glucose intolerance in C57BL/6J mice. Diabetes 55, 2153-2156.
51. Taconic (2008) C57BL/6JBomTac, C57BL/6NTac and C57BL/ 10SgSnAiTac mice do not carry the Nnt mutation. http://www. taconic.com/user-assets/Documents/Nnt- Mutation.pdf (accessed January 2009).
52. Cani PD, Bibiloni R, Knauf C, et al. (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470-1481.
53. Rader DJ, Alexander ET, Weibel GL, et al. (2008) Role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis. J Lipid Res 50, S189-S194.